Xeris Pharmaceuticals NASDAQ IPO

14/8/2018

IPO

Status:

Announced

Date:

14/8/2018

Overview:

Xeris Pharmaceuticals has raised $98 million with its IPO on NASDAQ.
Jefferies, Leerink Partners, RBC Capital Markets and Mizuho Securities acted as underwriters.

Daniel Semerdzhiev - Data analyst

Jurisdiction:

United States

Deal type:

IPO

Practice area:

Capital markets : Equity

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences

Firm:

Goodwin Procter

Party: Xeris Pharmaceuticals Inc (Issuer)

Lawyers: Joseph Theis Jr, Mitchell Bloom, Stuart Cable

Related deals